Philip Lackey is an Infectious Disease physician affiliated with Wake Forest University. OpenAlex indexes 17 publications with 583 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Medical Center Blvd
Winston Salem, NC 271573281
Telephone
336-716-2700Provider last certified this registry record 14 Apr 2023.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- PFIZER INC.Program year20242 payments
- ABBVIE INC.Program year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
85.9%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor37.3%Tivicay59%Dovato41%Part D<11 patientsFirst-generation cephalosporins13.5%Cephalexin100%Part D<11 patients+ 4 more classes in this area
Cardiovascular
7.6%Calcium channel blocker7.6%Amlodipine Besylate100%Part D<11 patientsMetabolism & gastrointestinal
6.5%Serotonin-3 Receptor Antagonist6.5%Ondansetron Odt100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 1264. Durability and effectiveness of fostemsavir in heavily treatment-experienced people with HIV
Open Forum Infectious Diseases
2022 - Antiretroviral therapy and liver disorders in the OPERA <sup>®</sup> cohort
Therapeutic Advances in Drug Safety
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Yeboah, MD
Wake Forest University
Bayard Powell, MD
Wake Forest University
Joseph Jorizzo, MD
Wake Forest University
Edward Haponik, MD
Wake Forest University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”